ZytoLight ® SPEC NRG1/CD74 TriCheckTM Probe

The ZytoLight ® SPEC NRG1/CD74 TriCheckTM Probe is designed to detect translocations involving the NRG1 gene and the CD74 gene. Using this probe it is possible to discriminate between CD74-NRG1 fusions and translocations affecting NRG1, but not CD74, such as SLC3A2-NRG1 or VAMP2-NRG1 fusions detected in various tumors.

NRG1 fusions constitute a good candidate for potential therapeutic applications.

Probe Maps


Ordering Information

Prod. No.:Tests¹ (Volume):Registration Status²:
20 (200 µl)

Download Information


1 Using 10 μl probe solution per test.
2 In vitro diagnostic medical device according to EU directive 98/79/EC. 
CE IVD only available in certain countries. All other countries research use only! 
Please contact your local dealer for more information.

ISO 9001
ISO 13485
ZytoVision GmbH


For ZytoVision products additional information is available, which is only valid outside the United States of America (USA). With this action you confirm that you have read this legal notice, that you agree with the terms of use, and that you are not intending to use the information provided on this website within USA.

Accept & Continue